Current extreme mesothelioma therapies consist of chemotherapy treatments, radiation therapies, medical treatments and experimental therapies and drugs. Study news reports the restricted success of present therapies for Mesothelioma

Mesothelioma research information suggests that standard therapies viz. single or multi-drug radiation treatment has a feedback rate of about 20 %. Radiation treatments, normally utilized in conjunction with surgery or chemotherapy treatments can ease discomfort and shrink tumors, making breathing easier. Nonetheless, radiation treatments can also cause serious side effects.

Efforts To Combat Mesothelioma.

Mesothelioma can take in between 10 and sixty years to establish after inhalation of respirable asbestos fibers, however Mesothelioma advances fast. Radical surgical treatments as mesothelioma treatments have actually had limited success. Surgical treatments tried consist of extra-pleural pneumonectomy (EPP) and pleurectomy.





Treatment information indicates that in EPP over 15 % patients die right after surgery. EPP includes removal of pleura, diaphragm, pericardium, part of the phrenic nerve and the whole tumor-affected lung and has to be supported by chemotherapy or radiation.

The pleurectomy therapies include removal of the pleura without eliminating the entire lung. These therapies are best in clients with good lung growth who have the tendency to gather fluid. In combination with radiation pleurectomy is reported in treatment information to have actually offered 22-month survival in 50 % and 24-month survival in 41 % cases in a 27-patient group with mesothelioma of the epithelial subtype.

Surgical therapies of mesothelioma have not been shown to offer substantial advantages over the restricted non-surgical therapies. Experimental drugs under evaluation consist of therapies by Onconase, Lovastatin and an Endostatin and angiostatin mix.

The Mesothelioma Research Foundation of America is funding research on mesothelioma remedy. The USC Norris Comprehensive Cancer Center in Los Angeles has actually completed Stage I Scientific Trials on a new mesothelioma treatment drug called Veglin.

Phase II Clinical trials of Veglin have begun in July 2004, opening amazing treatment possibilities for mesothelioma victims.







Share